Related Experiment Video
Updated: Jun 21, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
[Cognitive modifications associated with tobacco smoking].
Marie Lecacheux1, Laurent Karila, Henri-Jean Aubin
1Université Paris-Sud, Le Kremlin Bicêtre, INSERM U669, Paris, Hôpital Paul Brousse, Villejuif, France.
Nicotine in tobacco temporarily improves attention and memory but long-term use accelerates cognitive decline and dementia risk. Further research is needed on nicotine
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Context:
- Tobacco use is a major cause of mortality and somatic diseases.
- Nicotine, a key component of tobacco, has short-term cognitive-enhancing effects.
- Cognitive disorders are often linked to addictive mechanisms associated with tobacco use.
Purpose:
- To review the literature on the relationship between tobacco, nicotine, and cognitive function.
- To synthesize findings on the short-term and long-term effects of nicotine on cognition.
- To evaluate the association between tobacco use and cognitive disorders, including dementia.
Summary:
- Short-term nicotine exposure enhances attention and memory in smokers and non-smokers.
- Long-term tobacco use is linked to accelerated dementia and cognitive deterioration, particularly affecting memory and processing speed.
- Prospective studies contradict earlier findings suggesting a protective effect of smoking, likely due to biases in older case-control studies.
Impact:
- Highlights the detrimental long-term cognitive effects of tobacco use, including increased dementia risk.
- Underscores the need for further investigation into nicotine's long-term impact and therapeutic potential for cognitive disorders.
- Informs public health strategies regarding tobacco cessation and the management of cognitive health.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
CNS Depressants: Alcohol and Nicotine
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV
